Spain: Miura invests in mental healthcare and emotional wellbeing in Spain
Miura Partners, a PE firm with offices in Barcelona and Madrid, has joined forces with the founders of the mental healthcare centres Centro Psicosanitario Galiani (Seville)...
UK: Juvenescence acquires Ro5 to boost R&D capabilities and drive pipeline
Juvenescence, a clinical stage AI-enabled biotech company, has acquired Ro5 Inc, a proprietary AI drug discovery company.
“The addition of Ro5’s AI platform significantly enhances...
Switzerland: Healthcare Holding Schweiz completes acquisition of Ino Medical Solutions
Healthcare Holding Schweiz, a Switzerland-based healthcare buy, build & technology platform, has completed the acquisition of Ino Medical Solutions in Rapperswil-Jona, a specialist provider...
Finland: Aedifica invests €47m in acquisition and development of care properties in Finland
Belgium-based healthcare REIT, Aedifica, has invested €47m (US$53.5m) in the acquisition and development of nine care properties in Finland.
“With these investments, we are delivering...
Sweden: Impilo closes Fund II at hard cap of €700m
Impilo, a Nordic investment company focused solely on investments in lower-mid-market Nordic healthcare companies, has announced the final closing of Fund II, its first...
Belgium: Aedifica and Cofinimmo reach agreement to unite and create Europe’s leading healthcare REIT
Belgium-based REITs, Aedifica and Cofinimmo have reached agreement on terms to create the leading Healthcare REIT in Europe.
The deal will be structured as an...
India: KKR provides US$600m financing to Manipal Group
KKR, a global investment firm, has provided a US$600m financing to the Manipal Group, and India-based conglomerate with major businesses across healthcare, education, and health insurance.
The...
UK: Assura adjourns shareholder meeting in wake of third bid from PHP
UK-listed diversified healthcare REIT Assura has decided to adjourn the meetings required to implement the cash offer from the KKR and Stonepeak consortium (Sana...
France: Sanofi to acquire Blueprint for up to US$9.5bn
R&D driven, AI-powered biopharma company, Sanofi, is to acquire Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis (SM).
Sanofi...
Germany: NKB co-invest IX reaches hard cap of €325m
Nord Holding has announced the third close of the second specialised co-investment fund, with capital commitments of approximately €325m (US$369m). With this final closing,...
















